The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...
Like many cancer patients, Michael Wolff wanted answers. But, like many cancer patients in 2015, he wasn't getting them.
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...
"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback